M&T Bank
NVAX icon

M&T Bank’s Novavax NVAX Stock Holding History

M&T Bank’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,186
Closed -$312K – 1618
2021
Q4 		$312K Buy
2,186
+60
+3% +$10.3K ﹤0.01% 1233
2021
Q3 		$441K Buy
2,126
+178
+9% +$39.2K ﹤0.01% 1065
2021
Q2 		$414K Sell
1,948
-1,521
-44% -$279K ﹤0.01% 1113
2021
Q1 		$629K Sell
3,469
-1,246
-26% -$248K ﹤0.01% 898
2020
Q4 		$526K Sell
4,715
-1
-0% -$106 ﹤0.01% 1021
2020
Q3 		$511K Sell
4,716
-38
-0.8% -$4.63K ﹤0.01% 974
2020
Q2 		$396K Buy
+4,754
New +$182K ﹤0.01% 1054
2015
Q3 		– Sell
-3,150
Closed -$702K – 1944
2015
Q2 		$702K Sell
3,150
-16
-0.5% -$2.81K ﹤0.01% 1038
2015
Q1 		$524K Sell
3,166
-48
-1% -$7.79K ﹤0.01% 1166
2014
Q4 		$382K Sell
3,214
-1,058
-25% -$111K ﹤0.01% 1331
2014
Q3 		$356K Buy
+4,272
New +$386K ﹤0.01% 1446

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

M&T Bank's NVAX Position: Q1 2022 in Review

M&T Bank sold out of Novavax (NVAX) in Q1 2022, closing a stake of 2,186 shares — an estimated $312K sold.

M&T Bank first reported a position in NVAX in Q3 2014 and held it in 11 quarters. The position peaked at $702K in Q2 2015. 381 funds tracked by Wall St. Rank hold NVAX as of Q1 2022.

  • M&T Bank reported no remaining Novavax position as of Q1 2022 after selling out during the quarter.
  • M&T Bank sold 2,186 Novavax shares in Q1 2022, an estimated $312K.
  • M&T Bank first reported a position in Novavax in Q3 2014 and held it in 11 quarters.
  • M&T Bank's Novavax position peaked at $702K in Q2 2015.
  • 381 funds tracked by Wall St. Rank held Novavax as of Q1 2022.

Based on M&T Bank's 13F filing for Q1 2022, filed 9 May 2022.